Related Experiment Videos
Irritable Bowel Syndrome
1UCLA/CURE Neuroenteric Disease Program, 11301 Wilshire Blvd Bldg 115, Room 213, Los Angeles, CA 90073, USA.
Current Treatment Options in Gastroenterology
|July 4, 2002
Summary
Irritable Bowel Syndrome (IBS) management focuses on patient reassurance and treating the most bothersome symptom. Effective treatments include antidepressants for pain, loperamide for diarrhea, and emerging therapies like probiotics and Chinese herbal medicines.
Area of Science:
- Gastroenterology
- Pharmacology
- Psychosomatic Medicine
Background:
- Irritable Bowel Syndrome (IBS) presents diagnostic and therapeutic challenges for clinicians and patients.
- Effective IBS management requires patient confidence, reassurance, and education about its functional nature and lack of long-term risks.
Purpose of the Study:
- To review current and emerging treatment strategies for Irritable Bowel Syndrome (IBS).
- To emphasize a comprehensive, multidisciplinary approach to IBS management.
Main Methods:
- Review of pharmacologic interventions, including antidepressants, loperamide, antispasmodics, and probiotics.
- Evaluation of complementary therapies such as Chinese herbal medicines.
- Discussion of investigational agents targeting serotonin receptors and other pathways.
- Emphasis on the biopsychosocial model for understanding and managing IBS.
Main Results:
- Tricyclic antidepressants and loperamide show superiority over placebo for IBS pain and diarrhea, respectively.
- The efficacy of fiber for IBS symptom relief is controversial.
- Probiotic therapy (Lactobacillus plantarum) and Chinese herbal medicines demonstrate significant improvements in IBS symptoms and quality of life.
- Targeted modulation of serotonin receptors (5-HT3, 5-HT4) represents a promising therapeutic avenue.
Conclusions:
- First-line IBS treatment should target the most bothersome symptom.
- A biopsychosocial approach integrating education, lifestyle modifications, pharmacotherapy, and psychosocial interventions is crucial for effective IBS management.
- Emerging therapies targeting gut-brain pathways offer new hope for IBS patients.